Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORLISTAT vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ORLISTAT vs OXALIPLATIN: Safety Overview

Metric ORLISTAT OXALIPLATIN
Total FAERS Reports 6,498 56,406
Deaths Reported 31 6,501
Death Rate 0.5% 11.5%
Hospitalizations 329 21,980
Average Patient Age 49.0 yrs 61.5 yrs
% Female Patients 83.9% 42.1%
FDA Approval Date Apr 23, 1999 Apr 28, 2011
Manufacturer H2-Pharma LLC Camber Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued